Artículos de revistas
Anti-inflammatory drug design by molecular hybridization approach
Date
2011Registration in:
Pharmaceuticals, v. 4, p. 1450-1474, 2011.
1424-8247
10.3390/ph4111450
ISSN1424-8247-2011-04-1450-1474.pdf
4083068210623663
3204277043366119
5435899068903487
9734333607975413
5737933639516944
0000-0003-4141-0455
Author
Universidade Estadual Paulista (Unesp)
Institutions
Abstract
The design of new drugs with better physiochemical properties, adequateabsorption, distribution, metabolism, and excretion, effective pharmacologic potency andlacking toxicity remains is a challenge. Inflammation is the initial trigger of severaldifferent diseases, such as Alzheimer s disease, asthma, atherosclerosis, colitis, rheumatoidarthritis, depression, cancer; and disorders such as obesity and sexual dysfunction.Although inflammation is not the direct cause of these disorders, inflammatory processesoften increase related pain and suffering. New anti-inflammatory drugs developed usingmolecular hybridization techniques to obtain multiple-ligand drugs can act at one or multipletargets, allowing for synergic action and minimizing toxicity. This work is a review of newanti-inflammatory drugs developed using the molecular modification approach.